Skip to content

CelltaGen

셀타젠 Genetic Genotyping

Menu
  • Home
  • RNA
  • Assay
  • DNA
  • Plant
  • Guinea
  • Distributors
Menu

CREG2 Rabbit Polyclonal Antibody

CREG2 Rabbit Polyclonal Antibody

Protein CREG2 (CREG2) Antibody

abx027814-80l Abbexa 80 µl 343.2 EUR

CREG2 Antibody

DF15975 Affbiotech 100ul 420 EUR

CREG2 antibody

70R-5475 Fitzgerald 50 ug 560.4 EUR
Description: Rabbit polyclonal CREG2 antibody raised against the N terminal of CREG2

Anti-CREG2 antibody

STJ192447 St John's Laboratory 200 µl 236.4 EUR
Description: Unconjugated Rabbit polyclonal to CREG2

Mouse Protein CREG2, Creg2 ELISA KIT

ELI-32332m Lifescience Market 96 Tests 1038 EUR

Human Protein CREG2, CREG2 ELISA KIT

ELI-33746h Lifescience Market 96 Tests 988.8 EUR

CREG2 siRNA

20-abx912783 Abbexa
  • 661.20 EUR
  • 878.40 EUR
  • 15 nmol
  • 30 nmol

CREG2 siRNA

20-abx912784 Abbexa
  • 661.20 EUR
  • 878.40 EUR
  • 15 nmol
  • 30 nmol

CREG2 Blocking Peptide

33R-9827 Fitzgerald 100 ug 216 EUR
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of CREG2 antibody, catalog no. 70R-5475

Mouse CREG2 shRNA Plasmid

20-abx982923 Abbexa
  • 961.20 EUR
  • 1345.20 EUR
  • 150 µg
  • 300 µg

Human CREG2 shRNA Plasmid

20-abx966249 Abbexa
  • 961.20 EUR
  • 1345.20 EUR
  • 150 µg
  • 300 µg

CREG2 Recombinant Protein (Mouse)

RP125960 ABM 100 ug Ask for price

CREG2 Recombinant Protein (Human)

RP053098 ABM 100 ug Ask for price

CREG2 ORF Vector (Human) (pORF)

ORF017700 ABM 1.0 ug DNA 486 EUR

Creg2 ORF Vector (Mouse) (pORF)

ORF041988 ABM 1.0 ug DNA 607.2 EUR

CREG2 sgRNA CRISPR Lentivector set (Human)

K0506301 ABM 3 x 1.0 ug 406.8 EUR

Creg2 sgRNA CRISPR Lentivector set (Mouse)

K3754301 ABM 3 x 1.0 ug 406.8 EUR

CREG2 sgRNA CRISPR Lentivector (Human) (Target 1)

K0506302 ABM 1.0 ug DNA 184.8 EUR

CREG2 sgRNA CRISPR Lentivector (Human) (Target 2)

K0506303 ABM 1.0 ug DNA 184.8 EUR

CREG2 sgRNA CRISPR Lentivector (Human) (Target 3)

K0506304 ABM 1.0 ug DNA 184.8 EUR

Creg2 sgRNA CRISPR Lentivector (Mouse) (Target 1)

K3754302 ABM 1.0 ug DNA 184.8 EUR

Creg2 sgRNA CRISPR Lentivector (Mouse) (Target 2)

K3754303 ABM 1.0 ug DNA 184.8 EUR

Creg2 sgRNA CRISPR Lentivector (Mouse) (Target 3)

K3754304 ABM 1.0 ug DNA 184.8 EUR

CREG2 Protein Vector (Human) (pPB-C-His)

PV070797 ABM 500 ng 662.4 EUR

CREG2 Protein Vector (Human) (pPB-N-His)

PV070798 ABM 500 ng 662.4 EUR
×

CREG2 Rabbit Polyclonal Antibody

Recent Posts

  • Compare antibodies lab reagents for research
  • Compare polyclonal lab reagents for research
  • Assay Lab Reagents for Research
  • TEST Lab Reagents for Research
  • Advances on human amniotic epithelial cells and its clinical application potential

RSS Trends in Genetics

  • People with disability and privacy in precision medicine research: what’s at stake?
  • Complexities of mammalian transcriptome revealed by targeted RNA enrichment techniques
  • Clinical progress in genome-editing technology and in vivo delivery techniques
  • Polygenic sex determination in vertebrates – is there any such thing?
  • Emerging regulatory mechanisms of noncoding RNAs in topologically associating domains
  • RNA out of the mist
  • Consequences of trisomy syndromes – 21 and beyond
  • A proposed metric set for evaluation of genome assembly quality
  • Host genetic variability and determinants of severe COVID-19

Categories

  • 4 Host
  • 96T
  • apoptosis
  • array
  • Assay
  • Bacteria
  • DNA
  • Establishment and characterization of HBV-associated B lymphocytes with an immortalization potential.
  • GMO
  • Goat
  • Green
  • Guinea
  • Malignant transformation in a Breast Adenomyoepithelioma Caused by Amplification of c-MYC: A Common pathway to Cancer in a Rare Entity.
  • Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new players.
  • Pig
  • Pigeon
  • PITX1 protein interacts with ZCCHC10 to regulate hTERT mRNA transcription.
  • Plant
  • plasmid
  • Plate
  • PTPN14 degradation by high-risk human papillomavirus E7 limits keratinocyte differentiation and contributes to HPV-mediated oncogenesis.
  • RNA
  • SMR peptide antagonizes mortalin promoted release of extracellular vesicles and affects mortalin protection from complement-dependent cytotoxicity in breast cancer cells and leukemia cells.

Recent Posts

  • Compare antibodies lab reagents for research
  • Compare polyclonal lab reagents for research
  • Assay Lab Reagents for Research
  • TEST Lab Reagents for Research
  • Advances on human amniotic epithelial cells and its clinical application potential

RSS Trends in Genetics

  • People with disability and privacy in precision medicine research: what’s at stake?
  • Complexities of mammalian transcriptome revealed by targeted RNA enrichment techniques
  • Clinical progress in genome-editing technology and in vivo delivery techniques
  • Polygenic sex determination in vertebrates – is there any such thing?
  • Emerging regulatory mechanisms of noncoding RNAs in topologically associating domains
  • RNA out of the mist
  • Consequences of trisomy syndromes – 21 and beyond
  • A proposed metric set for evaluation of genome assembly quality
  • Host genetic variability and determinants of severe COVID-19

Categories

  • 4 Host
  • 96T
  • apoptosis
  • array
  • Assay
  • Bacteria
  • DNA
  • Establishment and characterization of HBV-associated B lymphocytes with an immortalization potential.
  • GMO
  • Goat
  • Green
  • Guinea
  • Malignant transformation in a Breast Adenomyoepithelioma Caused by Amplification of c-MYC: A Common pathway to Cancer in a Rare Entity.
  • Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new players.
  • Pig
  • Pigeon
  • PITX1 protein interacts with ZCCHC10 to regulate hTERT mRNA transcription.
  • Plant
  • plasmid
  • Plate
  • PTPN14 degradation by high-risk human papillomavirus E7 limits keratinocyte differentiation and contributes to HPV-mediated oncogenesis.
  • RNA
  • SMR peptide antagonizes mortalin promoted release of extracellular vesicles and affects mortalin protection from complement-dependent cytotoxicity in breast cancer cells and leukemia cells.

Recent Posts

  • Compare antibodies lab reagents for research
  • Compare polyclonal lab reagents for research
  • Assay Lab Reagents for Research
  • TEST Lab Reagents for Research
  • Advances on human amniotic epithelial cells and its clinical application potential
© 2023 CelltaGen | Powered by Superbs Personal Blog theme